| 股號 / 名稱 | 現金及約當現金 | 流動資產 | 總資產 |
| ABBV 艾伯維 | 12,814,000,000.0 | 33,002,000,000.0 | 134,711,000,000.0 |
| AZN AstraZeneca PLC | 5,840,000,000.0 | 25,054,000,000.0 | 101,119,000,000.0 |
| AMGN 美國安進 | 10,944,000,000.0 | 30,332,000,000.0 | 97,154,000,000.0 |
| BMY 施貴寶 | 11,464,000,000.0 | 31,770,000,000.0 | 95,159,000,000.0 |
| GILD 吉利德科學 | 6,085,000,000.0 | 16,085,000,000.0 | 62,125,000,000.0 |
| REGN 雷傑納榮製藥 | 2,730,000,000.0 | 19,479,200,000.0 | 33,080,200,000.0 |
| BIIB Biogen Inc | 1,049,900,000.0 | 6,859,300,000.0 | 26,844,800,000.0 |
| VRTX 福泰製藥 | 10,369,100,000.0 | 14,144,200,000.0 | 22,730,200,000.0 |
| MRNA 莫德納 | 2,907,000,000.0 | 10,325,000,000.0 | 18,426,000,000.0 |
| BIO.B Bio Rad Laboratories Inc | 403,815,000.0 | 3,048,330,000.0 | 12,299,070,000.0 |
| ILMN Illumina Inc | 1,048,000,000.0 | 2,609,000,000.0 | 10,111,000,000.0 |
| ROIV Roivant Sciences Ltd | 6,670,810,000.0 | 6,806,733,000.0 | 7,312,679,000.0 |
| BMRN Biomarin Pharmaceutical Inc | 755,127,000.0 | 2,956,088,000.0 | 6,841,603,000.0 |
| INCY 英賽德 | 3,213,376,000.0 | 4,645,402,000.0 | 6,782,107,000.0 |
| EXAS Exact Sciences Corp | 605,378,000.0 | 1,194,369,000.0 | 6,471,334,000.0 |
| QGEN Qiagen NV | 668,084,000.0 | 2,147,560,000.0 | 6,115,190,000.0 |
| BGNE Beigene Ltd | 3,171,800,000.0 | 4,203,414,000.0 | 5,805,275,000.0 |
| ARGX argenx SE | 2,048,844,000.0 | 4,123,737,000.0 | 4,542,458,000.0 |
| ALNY Alnylam Pharmaceuticals Inc | 812,688,000.0 | 2,982,697,000.0 | 3,829,880,000.0 |
| SRPT Sarepta Therapeutics Inc | 428,430,000.0 | 2,579,331,000.0 | 3,264,576,000.0 |
| EXEL Exelixis Inc | 262,994,000.0 | 1,317,958,000.0 | 2,942,357,000.0 |
| RGEN Repligen Corp | 751,323,000.0 | 1,111,043,000.0 | 2,824,411,000.0 |
| TECH Bio-Techne Corp | 130,132,000.0 | 590,640,000.0 | 2,730,753,000.0 |
| CRSP CRISPR Therapeutics AG | 389,477,000.0 | 1,908,078,000.0 | 2,229,571,000.0 |
| ALKS Alkermes Plc | 457,469,000.0 | 1,485,506,000.0 | 2,136,223,000.0 |
| VIR Vir Biotechnology Inc | 241,576,000.0 | 1,588,226,000.0 | 1,919,060,000.0 |
| LEGN Legend Biotech Corp | 1,277,713,000.0 | 1,497,799,000.0 | 1,848,609,000.0 |
| EBS Emergent BioSolutions Inc | 111,700,000.0 | 679,500,000.0 | 1,823,200,000.0 |
| NVAX Novavax Inc | 568,505,000.0 | 1,143,888,000.0 | 1,797,490,000.0 |
| GH Guardant Health Inc | 1,133,537,000.0 | 1,347,106,000.0 | 1,786,421,000.0 |
| HALO Halozyme Therapeutics Inc | 118,370,000.0 | 746,424,000.0 | 1,733,270,000.0 |
| NEO Neogenomics Inc | 342,488,000.0 | 596,812,000.0 | 1,681,229,000.0 |
| DNA Ginkgo Bioworks Holdings Inc | 944,073,000.0 | 1,001,749,000.0 | 1,665,342,000.0 |
| CERT Certara Inc | 234,951,000.0 | 340,201,000.0 | 1,563,140,000.0 |
| RARE Ultragenyx Pharmaceutical Inc | 213,584,000.0 | 732,184,000.0 | 1,491,013,000.0 |
| ABCL Abcellera Biologics Inc | 133,320,000.0 | 871,985,000.0 | 1,488,094,000.0 |
| MRVI Maravai LifeSciences Holdings Inc | 574,962,000.0 | 699,912,000.0 | 1,487,450,000.0 |
| BEAM Beam Therapeutics Inc | 435,895,000.0 | 1,211,043,000.0 | 1,459,714,000.0 |
| PCVX Vaxcyte Inc | 397,451,000.0 | 1,095,954,000.0 | 1,407,917,000.0 |
| INSM Insmed Inc | 482,374,000.0 | 929,063,000.0 | 1,329,837,000.0 |
| ARVN Arvinas Inc | 311,700,000.0 | 1,280,200,000.0 | 1,304,600,000.0 |
| HCM HUTCHMED (China) Ltd | 283,589,000.0 | 1,096,839,000.0 | 1,279,773,000.0 |
| DNLI Denali Therapeutics Inc | 127,106,000.0 | 1,064,137,000.0 | 1,153,917,000.0 |
| MYGN Myriad Genetics Inc | 132,100,000.0 | 313,600,000.0 | 1,146,500,000.0 |
| RCUS Arcus Biosciences Inc | 127,000,000.0 | 831,000,000.0 | 1,095,000,000.0 |
| BPMC Blueprint Medicines Corp | 71,286,000.0 | 808,393,000.0 | 1,049,250,000.0 |
| ZLAB Zai Lab Ltd | 790,151,000.0 | 939,606,000.0 | 1,036,295,000.0 |
| DVAX Dynavax Technologies Corp | 150,279,000.0 | 859,120,000.0 | 997,096,000.0 |
| XENE Xenon Pharmaceuticals Inc | 148,643,000.0 | 644,962,000.0 | 964,798,000.0 |
| ANIP ANI Pharmaceuticals Inc | 221,121,000.0 | 519,816,000.0 | 904,422,000.0 |
| QURE Uniqure NV | 241,360,000.0 | 651,853,000.0 | 831,689,000.0 |
| AMRN Amarin Corporation PLC | 199,252,000.0 | 724,981,000.0 | 831,684,000.0 |
| ACLX Arcellx Inc | 394,583,000.0 | 716,363,000.0 | 825,132,000.0 |
| CYTK Cytokinetics Inc | 113,024,000.0 | 628,051,000.0 | 824,316,000.0 |
| KRYS Krystal Biotech Inc | 358,328,000.0 | 587,909,000.0 | 818,355,000.0 |
| HRMY Harmony Biosciences Holdings Inc | 311,660,000.0 | 451,070,000.0 | 811,448,000.0 |
| TVTX Travere Therapeutics Inc | 58,176,000.0 | 616,775,000.0 | 788,913,000.0 |
| APLS Apellis Pharmaceuticals Inc | 351,185,000.0 | 766,331,000.0 | 788,730,000.0 |
| LGND Ligand Pharmaceuticals Inc | 22,954,000.0 | 237,429,000.0 | 787,216,000.0 |
| IOVA Iovance Biotherapeutics Inc | 114,888,000.0 | 307,848,000.0 | 780,351,000.0 |
| FOLD Amicus Therapeutics Inc | 246,994,000.0 | 483,061,000.0 | 777,880,000.0 |
| ACAD ACADIA Pharmaceuticals Inc | 188,657,000.0 | 616,125,000.0 | 748,956,000.0 |
| TWST Twist Bioscience Corp | 266,269,000.0 | 390,231,000.0 | 732,815,000.0 |
| NUVL Nuvalent Inc | 335,387,000.0 | 726,488,000.0 | 732,384,000.0 |
| ITCI Intra-Cellular Therapies Inc | 147,767,000.0 | 667,799,000.0 | 728,295,000.0 |
| SWTX SpringWorks Therapeutics Inc | 176,053,000.0 | 500,912,000.0 | 725,788,000.0 |
| MORF Morphic Holding Inc | 58,577,000.0 | 716,928,000.0 | 722,514,000.0 |
| IMVT Immunovant Inc | 690,937,000.0 | 710,776,000.0 | 711,446,000.0 |
| PRTA Prothena Corporation PLC | 618,830,000.0 | 639,282,000.0 | 696,382,000.0 |
| MESO Mesoblast Ltd | 77,144,000.0 | 85,154,000.0 | 670,285,000.0 |
| ITOS Iteos Therapeutics Inc | 251,177,000.0 | 550,652,000.0 | 667,588,000.0 |
| ADPT Adaptive Biotechnologies Corp | 65,064,000.0 | 410,188,000.0 | 661,134,000.0 |
| IDYA IDEAYA Biosciences Inc | 157,018,000.0 | 532,632,000.0 | 649,316,000.0 |
| VNDA Vanda Pharmaceuticals Inc | 135,821,000.0 | 432,946,000.0 | 648,440,000.0 |
| MIRM Mirum Pharmaceuticals Inc | 286,326,000.0 | 387,541,000.0 | 646,621,000.0 |
| CHRS Coherus BioSciences Inc | 102,891,000.0 | 475,631,000.0 | 629,604,000.0 |
| RNA Avidity Biosciences Inc | 185,082,000.0 | 611,307,000.0 | 628,555,000.0 |
| ALEC Alector Inc | 74,555,000.0 | 565,807,000.0 | 621,827,000.0 |
| NUVB Nuvation Bio Inc | 42,649,000.0 | 616,434,000.0 | 621,484,000.0 |
| SNDX Syndax Pharmaceuticals Inc | 295,394,000.0 | 580,876,000.0 | 612,880,000.0 |
| ME 23andMe Holding Co. | 242,418,000.0 | 309,959,000.0 | 608,211,000.0 |
| ETNB 89Bio Inc | 316,161,000.0 | 593,534,000.0 | 596,269,000.0 |
| BCYC Bicycle Therapeutics PLC | 526,423,000.0 | 561,868,000.0 | 595,344,000.0 |
| AVIR Atea Pharmaceuticals Inc | 143,823,000.0 | 590,455,000.0 | 594,968,000.0 |
| AXSM Axsome Therapeutics Inc | 386,193,000.0 | 504,263,000.0 | 588,236,000.0 |
| ZYME Zymeworks Inc | 157,557,000.0 | 412,926,000.0 | 580,880,000.0 |
| AKRO Akero Therapeutics Inc | 234,207,000.0 | 559,962,000.0 | 580,271,000.0 |
| KYMR Kymera Therapeutics Inc | 109,966,000.0 | 405,317,000.0 | 575,759,000.0 |
| RGNX Regenxbio Inc | 34,522,000.0 | 334,971,000.0 | 573,970,000.0 |
| RCKT Rocket Pharmaceuticals Inc | 55,904,000.0 | 378,222,000.0 | 566,341,000.0 |
| TSVT 2Seventy Bio Inc | 74,958,000.0 | 237,765,000.0 | 565,426,000.0 |
| SANA Sana Biotechnology Inc | 133,517,000.0 | 213,515,000.0 | 565,299,000.0 |
| ZNTL Zentalis Pharmaceuticals Inc | 28,038,000.0 | 496,718,000.0 | 551,688,000.0 |
| REPL Replimune Group Inc | 97,672,000.0 | 479,164,000.0 | 532,930,000.0 |
| KNSA Kiniksa Pharmaceuticals Ltd | 107,954,000.0 | 276,297,000.0 | 526,322,000.0 |
| BHVN Biohaven Ltd | 248,402,000.0 | 442,446,000.0 | 513,212,000.0 |
| PLRX Pliant Therapeutics Inc | 63,234,000.0 | 505,502,000.0 | 512,154,000.0 |
| FATE Fate Therapeutics Inc | 41,870,000.0 | 331,540,000.0 | 506,217,000.0 |
| IBRX Immunitybio Inc | 265,453,000.0 | 294,084,000.0 | 504,452,000.0 |
| EDIT Editas Medicine Inc | 123,652,000.0 | 340,829,000.0 | 499,153,000.0 |
載入數據中...
最新要聞
和生物製藥相關的產業概念股
生物製藥概念股相關指標排名
生物製藥每月營收
生物製藥每股盈餘
生物製藥每股淨值
生物製藥損益表
生物製藥總資產
生物製藥負債和股東權益
生物製藥現金流量表
生物製藥利潤比率
生物製藥營業費用率拆解
生物製藥杜邦分析
生物製藥ROE / ROA
生物製藥經營週轉能力
生物製藥營運週轉天數
生物製藥現金股利發放率
生物製藥財務結構比率
生物製藥流速動比率
生物製藥利息保障倍數
生物製藥現金流量分析
生物製藥營業現金流對淨利比
生物製藥盈餘再投資比率
生物製藥月營收成長率
生物製藥營收成長率
生物製藥毛利成長率
生物製藥營業利益成長率
生物製藥稅後淨利成長率
生物製藥每股盈餘成長率
生物製藥本益比評價
生物製藥股價淨值比評價
生物製藥現金股利殖利率
生物製藥平均現金股息殖利率
生物製藥董監持股比例
生物製藥董監持股質押比例